Mirae Asset Global ETFs Holdings
CLYM icon

Mirae Asset Global ETFs Holdings’s Climb Bio CLYM Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Buy
+16,153
New +$167K ﹤0.01% 2458
2025
Q2 		– Sell
-17,618
Closed -$21.5K – 3295
2025
Q1 		$21.5K Buy
17,618
+786
+5% +$1.27K ﹤0.01% 2978
2024
Q4 		$30.3K Buy
16,832
+768
+5% +$2.78K ﹤0.01% 2969
2024
Q3 		$81.8K Buy
+16,064
New +$114K ﹤0.01% 2789

Other funds holding CLYM

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Frontier Capital Management
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mirae Asset Global ETFs Holdings's CLYM Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Climb Bio (CLYM) in Q2 2026: 16,153 shares worth $211K. The stake represents ﹤0.01% of the portfolio and ranks #2458 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in CLYM as recently as Q1 2025.

Mirae Asset Global ETFs Holdings first reported a position in CLYM in Q3 2024 and has held it in 4 quarters since. 108 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 16,153 shares of Climb Bio worth $211K as of Q2 2026.
  • Climb Bio was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
  • Climb Bio made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2458 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Climb Bio in Q3 2024 and has held it in 4 quarters since.
  • 108 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.